المؤلفون: Williams, Thomas, Tur Gomez, Carmen, Eshaghi, Arman, Doshi, Anisha, Chan, Dennis, Binks, Sophie

المساهمون: Institut Català de la Salut, Williams T Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. Tur C Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Eshaghi A, Doshi A Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. Chan D UCL Institute of Cognitive Neuroscience, University College London, London, UK. Binks S Department of Neurology, Nuffield Department of Clinical Neurosciences, Oxford, UK, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Imatgeria, Trastorns de la cognició - Imatgeria, PSYCHIATRY AND PSYCHOLOGY::Mental Disorders::Neurocognitive Disorders::Cognition Disorders::Cognitive Dysfunction, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Amino Acids, and Proteins::Proteins::Nerve Tissue Proteins::Neurofilament Proteins, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::Other subheadings::/diagnostic imaging, PSIQUIATRÍA Y PSICOLOGÍA::trastornos mentales::trastornos neurocognitivos::trastornos cognitivos::disfunción cognitiva, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::aminoácidos, péptidos y proteínas::proteínas::proteínas del tejido nervioso::proteínas de neurofilamentos, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::Otros calificadores::/diagnóstico por imagen

وصف الملف: application/pdf

العلاقة: Multiple Sclerosis Journal;28(12); https://doi.org/10.1177/13524585221114441Test; Williams T, Tur C, Eshaghi A, Doshi A, Chan D, Binks S, et al. Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial. Mult Scler J. 2022 Oct;28(12):1913–26.; https://hdl.handle.net/11351/8664Test; 000839253300001

الإتاحة: https://doi.org/10.1177/13524585221114441Test
https://hdl.handle.net/11351/8664Test

المؤلفون: Bittner, Stefan, Kubala Havrdova, Eva, Tintore Subirana, Mar, Zipp, Frauke, Oh, Jiwon

المساهمون: Institut Català de la Salut, Bittner S, Zipp F Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz 55131, Germany. Oh J Division of Neurology, Department of Medicine, St Michael’s Hospital, University of Toronto, Toronto, Ontario M5S 3H2, Canada. Kubala Havrdová E Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague 116 36, Czech Republic. Tintoré M Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Imatgeria per ressonància magnètica, Filaments citoplasmàtics, Esclerosi múltiple - Prognosi, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Amino Acids, and Proteins::Proteins::Nerve Tissue Proteins::Neurofilament Proteins, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::Other subheadings::/diagnostic imaging, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::aminoácidos, péptidos y proteínas::proteínas::proteínas del tejido nervioso::proteínas de neurofilamentos, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::Otros calificadores::/diagnóstico por imagen, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico

وصف الملف: application/pdf

العلاقة: Brain;144(10); https://doi.org/10.1093/brain/awab241Test; Bittner S, Oh J, Kubala Havrdová E, Tintoré M, Zipp F. The potential of serum neurofilament as biomarker for multiple sclerosis. Brain. 2021 Oct;144(10):2954–63.; https://hdl.handle.net/11351/7631Test; 000733375400012

الإتاحة: https://doi.org/10.1093/brain/awab241Test
https://hdl.handle.net/11351/7631Test

المؤلفون: Thomas Williams, Carmen Tur, Arman Eshaghi, Anisha Doshi, Dennis Chan, Sophie Binks, Henny Wellington, Amanda Heslegrave, Henrik Zetterberg, Jeremy Chataway

المساهمون: Institut Català de la Salut, [Williams T] Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. [Tur C] Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Eshaghi A, Doshi A] Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK. [Chan D] UCL Institute of Cognitive Neuroscience, University College London, London, UK. [Binks S] Department of Neurology, Nuffield Department of Clinical Neurosciences, Oxford, UK, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Multiple Sclerosis, Intermediate Filaments, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], Otros calificadores::Otros calificadores::/diagnóstico por imagen [Otros calificadores], Amino Acids, Peptides, and Proteins::Proteins::Amino Acids, Peptides, and Proteins::Proteins::Nerve Tissue Proteins::Neurofilament Proteins [CHEMICALS AND DRUGS], Multiple Sclerosis, Chronic Progressive, Magnetic Resonance Imaging, Esclerosi múltiple - Imatgeria, Neurology, Neurofilament Proteins, Trastorns de la cognició - Imatgeria, Mental Disorders::Neurocognitive Disorders::Cognition Disorders::Cognitive Dysfunction [PSYCHIATRY AND PSYCHOLOGY], enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Humans, Cognitive Dysfunction, aminoácidos, péptidos y proteínas::proteínas::aminoácidos, péptidos y proteínas::proteínas::proteínas del tejido nervioso::proteínas de neurofilamentos [COMPUESTOS QUÍMICOS Y DROGAS], Neurology (clinical), Other subheadings::Other subheadings::/diagnostic imaging [Other subheadings], trastornos mentales::trastornos neurocognitivos::trastornos cognitivos::disfunción cognitiva [PSIQUIATRÍA Y PSICOLOGÍA], Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b04435a80c2bca75621ed3be0f0c612Test
https://doi.org/10.1177/13524585221114441Test

المؤلفون: Eva Havrdova, Stefan Bittner, Jiwon Oh, Frauke Zipp, Mar Tintoré

المساهمون: Institut Català de la Salut, [Bittner S, Zipp F] Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz 55131, Germany. [Oh J] Division of Neurology, Department of Medicine, St Michael’s Hospital, University of Toronto, Toronto, Ontario M5S 3H2, Canada. [Kubala Havrdová E] Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague 116 36, Czech Republic. [Tintoré M] Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Brain
Scientia

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Treatment response, Multiple Sclerosis, Neurofilament, Filaments citoplasmàtics, Disease, neurofilament, Updates, Neurofilament Proteins, Internal medicine, medicine, Humans, aminoácidos, péptidos y proteínas::proteínas::aminoácidos, péptidos y proteínas::proteínas::proteínas del tejido nervioso::proteínas de neurofilamentos [COMPUESTOS QUÍMICOS Y DROGAS], Longitudinal Studies, Subclinical disease, Diagnosis::Prognosis [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Esclerosi múltiple - Imatgeria per ressonància magnètica, diagnóstico::pronóstico [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Other subheadings::Other subheadings::/diagnostic imaging [Other subheadings], AcademicSubjects/SCI01870, business.industry, therapy response, Multiple sclerosis, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], biomarkers, Otros calificadores::Otros calificadores::/diagnóstico por imagen [Otros calificadores], Amino Acids, Peptides, and Proteins::Proteins::Amino Acids, Peptides, and Proteins::Proteins::Nerve Tissue Proteins::Neurofilament Proteins [CHEMICALS AND DRUGS], Prognosis, medicine.disease, Esclerosi múltiple - Prognosi, Magnetic Resonance Imaging, Clinical trial, Early results, enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Biomarker (medicine), AcademicSubjects/MED00310, Neurology (clinical), business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f989a94f437c402ca2a1ad55039f8faTest
https://doi.org/10.1093/brain/awab241Test